Диссертация (1139693), страница 27
Текст из файла (страница 27)
New and emergingtreatment for the functional // GI disorders. AGA Postgraduate Course, May 18-19,2002, pp.35-4170.Clarke G., McKernan D.P. et al. A Distinct Profile of Tryptophan Metabolismalong the Kynurenine Pathway Downstream of Toll-Like Receptor Activation inIrritable Bowel Syndrome // Front Pharmacol.
– 2012. – Vol. 3. – P. 9071.Comelli E.M., Simmering R., Faure M. et al. Multifaceted transcriptionalregulation of the murine intestinal mucus layer by endogenous microbiota //Genomics. – 2008. – Vol. 91. – P. 70-772.Connor T.J., Leonard B.E. Depression, stress and immunological activation:The role of cytokines in depressive disorders // Life Sciences. – 2000. – Vol.
62. –p. 583-606.73.Corinaldesi R et al. Effect of mesalazine on mucosal immune biomarkers inirritable bowel syndrome: a randomized controlled proof-of-concept study. //Aliment PharmacolTher.2009 Aug;30(3):245-52;74.Corsetti M., Whorwell P. Expert Review of Gastroenterology & Hepatology.2016 Jul;10(7):807-1575.Corsetti M., Whorwell Peter. Novel pharmacological therapies for irritablebowelsyndrome.ExpertReviewofGastroenterology&Hepatology,DOI:10.1586/17474124.2016.1158099; N.J.Talley, G. Holtmann, M.M. Walker.Therapeutic strategies for functional dyspepsia and irritable bowel syndrome basedon pathophysiology. J Gastroenterol.
2015 Jun;50(6):601-1376.Corsetti M, Tack J. New pharmacological treatment options for chronicconstipation. Expert Opin Pharmacother. 2014 May;15(7):927-4123677.Creed F. Relationship between IBS and psychiatric disorder // Irritable bowelsyndrome (Ed. M. Camilleri, R. C. Spiller), 2002. – p.45-5478.Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, DeGiorgio R, Stanghellini V, Corinaldesi R, Barbara G. Mucosal immune activationin irritable bowel syndrome: gender-dependence and association with digestivesymptoms.
Am J Gastroenterol. 2009;104:392–400.79.forCrentsil V. Will corticosteroids and other anti-inflammatory agents be effectivediarrhea-predominantirritablebowelsyndrome?//MedHypotheses.2005;65(1):97-10280.Crobach M.J.T., Planche T., Eckert C., Barbut F., et al. European society ofclinical microbiology and infectious diseases: Update of the diagnostic guidancedocument for Clostridium difficile infection.
Clin Microbiol Infect 2016; 22:63-81.81.Culligan E.P., Sleator R.D. Advances in the microbiome: Applications toClostridium difficile infection. Article ID 916826. J Clin Med 2016; 5(9)82.Dantzer R. Cytokine-induced sickness behavior: where do we stand? // Brain,Behavior, and Immunity. – 2001. – Vol. 15. – p. 7-24.83.Daoud, H and B.Hani. Lactic Acid Bacteria as Probiotics: Characteristics,Selection Criteria and Role in Immunomodulation of Human GI Mucosal Barrier.pp.
197-216. Croatia: Marcelino, Kongo, 201384.Davies K.A., Longshaw C.M., Davis G.L., Bouza E., et al. Underdiagnosis ofClostridium difficile across Europe: the European, multicentre, prospective,biannual, point-prevalence study of Clostridium difficile infection in hospitalisedpatients with diarrhoea (EUCLID). Lancet Infect Dis 2014; 14(12):1208-1985.Dekel R, Drossman DA, Sperber AD. The use of psychotropic drugs inirritable bowel syndrome. Expert Opin Investig Drugs.
2013 Mar;22(3):329-3986.Dinan T.G., Quigley E.M., Ahmed S.M. et al. Hypothalamic-pituitary-gut axisdysregulation in irritable bowel syndrome: plasma cytokines as a potentialbiomarker? //Gastroenterology. – 2006. – Vol. 130. - № 2. – p. 304-311.87.Dinan TG, Cryan JF. Melancholic microbes: a link between gut microbiota anddepression? Neurogastroenterol Motil.
– 2013. – Vol. 25. – №9. – P. 713-923788.Drossman D. A., McKee D. C., Sandier R. S., et al. Psychosocial factors in theirritable bowel syndrome. // Gastroenterology. 1988 -N 95, pp. 701 – 70889.Drossman D.A. Integrated approach to irritable bowel syndrome // WorldGastroenterology News. - 2004. – Vol.
9. – Iss. 1. – p. 11-12.90.Drossman DA, Thompson WG. I irritable bowel syndrome: a graduated,multicomponent treatment approach. // Ann Intern Med 1992 - N 116, pp.1009101691.Duran F.G., Castellano V., Ciriza C. et al. Relationship betweenirritablebowel syndrome and colonic inflammation // Gut.
An International Journal ofGastroenterology and Hepatology. – 2008. - Vol.57.- A 37792.Edoardo Savarino,Manuele Furnari,Andrea Ottonello, Vincenzo Savarino. It isTime to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBSPatients. Am J Gastroenterol. 2016 Sep;111(9):1364)93.Engsbro AL., Begtrup LM., Kjeldsen J. et.al. Patients suspected of irritablebowel syndrome--cross-sectional study exploring the sensitivity of Rome IIIcriteria in primary care. Am J Gastroenterol. 2013 Jun;108(6):972-80. doi:10.1038/ajg.2013.15.
Epub 2013 Feb 1994.Feinle-Bisset C., Vozzo R., Horowitz M., Talley N.J. Diet, food intake anddisturbed physiology in the pathogenesis of symptoms in functional dyspepsia //Amer.J.Gastroenterol. – 2003. - Vol.99. – P.170-18195.Fichna J, Poole D, Veldhuis N. Transient receptor potential vanilloid 4 inhibitsmouse colonic motility by activating NO-dependent enteric neurotransmission. JMol Med (Berl). 2015 Dec;93(12):1297-30996.Fischer S, Nater UM. Functional somatic syndromes: asking aboutexclusionary medical conditions results in decreased prevalence and overlap rates.BMC Public Health. 2014 Oct 4;14:103497.Foley S.J., Singh G., Lau LC., Walls A.F. et al. Depressed serotonin transporterin platelets of patients with IBS and diarrhea (IBS-D) and coeliac disease: abiomarker a low grade inflammation in duodenal biopsies // Gut. – 2008.
- Vol.57.– A 9723898.Ford AC, Moayyedi P, Lacy BE, et.al. American College of Gastroenterologymonograph on the management of irritable bowel syndrome and chronic idiopathicconstipation. Am J Gastroenterol. 2014 Aug;109 Suppl 1:S2-2699.Ford AC, Quigley EMM, Lacy BE, et al.
Efficacy of prebiotics, probiotics, andsynbiotics in irritable bowel syndrome and chronic idiopathic constipation:systematic review and meta-analysis. Am J Gastroenterol 2014; 109:1547–1561100. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy ofantidepressants and psychological therapies in irritable bowel syndrome:systematic review and meta-analysis // Gut.2009 Mar;58(3):367-78101. Ford AC, Quigley EM, Lacy BE, et al. Effect of antidepressants andpsychological therapies, including hypnotherapy, in irritable bowel syndrome:systematic review and meta-analysis. Am J Gastroenterol 2014; 109:1350–1365102. Ford AC1, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P.
Efficacy ofantidepressants and psychological therapies in irritable bowel syndrome:systematic review and meta-analysis. Gut. 2009 Mar;58(3):367-78103. Foster J.A. Gut feelings: bacteria and the brain // Cerebrum. – 2013. – Vol. 1. –P. 9.104. Freud S. «The neuropsychoses of defence». S.E., III: London: Hogart press,1894a105. Gary M. Mawe, Jill M. Hoffman. Serotonin Signaling in the GastrointestinalTract: Functions, dysfunctions, and therapeutic targets. Nat. Rev.
Gastroenterol.Hepatol. 2013 Aug; 10(8): 473–486106. Gaudioso et al. Menthol pain relief through cumulative inactivation of voltage-gated sodium channels. Pain 2012,153:473–484;107. Gershon MD, Liu MT. Serotonin and neuroprotection in functional boweldisorders. Neurogastroenterol Motil. 2007; 19(Suppl 2):19–24108.
Gershon M.D. Nerves, reflexes, and the enteric nervous system: pathogenesisof the irritable bowel syndrome // J. Clin. Gastroenterol. – 2005. – Vol. 39. – Р.184–193109. Giamarellos-Bourboulis E.J., Pyleris E., Barbatzas Ch., Pistiki A., Pimentel M..239Small intestinal bacterial overgrowth is associated with irritable bowel syndromeand is independent of proton pump inhibitor usage. BMC Gastroenterol.
2016 Jul11;16(1):67110. Gonzales Gamarra RG, Ruiz Sánchez JG, León Jiménez F, Cubas Benavides F,Díaz Vélez C. [Prevalence of irritable bowel syndrome in the adult population ofthe city of Chiclayo in 2011] Rev Gastroenterol Peru. 2012;32:381–386.111. Greenwood-Van Meerveld B, Moloney RD, Johnson AC, Vicario M.Mechanisms of stress-induced visceral pain: implications in irritable bowelsyndrome. J Neuroendocrinol. 2016 Jan 8112. Guarner G, Aamir G. Khan, James Garisch et.al World GastroenterologyOrganisation Global Guidelines Probiotics and prebiotics October 2011113. Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome inAsia: something old, something new, something borrowed. J GastroenterolHepatol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
